company background image
BIOC logo

GlaxoSmithKlineE CASE:BIOC Stock Report

Last Price


Market Cap







28 Feb, 2024


Company Financials

BIOC Stock Overview

GlaxoSmithKline S.A.E. engages in the production of pharmaceutical chemicals in Egypt.

BIOC fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance2/6
Financial Health1/6


Risk Analysis

GlaxoSmithKline S.A.E Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GlaxoSmithKlineE
Historical stock prices
Current Share Priceج.م41.64
52 Week Highج.م47.50
52 Week Lowج.م23.11
1 Month Change12.27%
3 Month Change12.81%
1 Year Change22.83%
3 Year Change17.46%
5 Year Changen/a
Change since IPO346.78%

Recent News & Updates

Recent updates

Shareholder Returns

BIOCEG PharmaceuticalsEG Market

Return vs Industry: BIOC underperformed the EG Pharmaceuticals industry which returned 52.7% over the past year.

Return vs Market: BIOC underperformed the EG Market which returned 82.4% over the past year.

Price Volatility

Is BIOC's price volatile compared to industry and market?
BIOC volatility
BIOC Average Weekly Movement5.7%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement8.2%
10% most volatile stocks in EG Market11.8%
10% least volatile stocks in EG Market5.1%

Stable Share Price: BIOC has not had significant price volatility in the past 3 months.

Volatility Over Time: BIOC's weekly volatility (6%) has been stable over the past year.

About the Company

1981n/aAmr Mamdouh Majid

GlaxoSmithKline S.A.E. engages in the production of pharmaceutical chemicals in Egypt. It is also involved in the manufacture of medical preparations and cosmetics. The company was founded in 1981 and is headquartered in New Cairo City, Egypt.

GlaxoSmithKline S.A.E Fundamentals Summary

How do GlaxoSmithKlineE's earnings and revenue compare to its market cap?
BIOC fundamental statistics
Market capج.م3.48b
Earnings (TTM)ج.م193.21m
Revenue (TTM)ج.م2.10b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOC income statement (TTM)
Cost of Revenueج.م1.44b
Gross Profitج.م656.67m
Other Expensesج.م463.46m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date


Earnings per share (EPS)2.31
Gross Margin31.28%
Net Profit Margin9.20%
Debt/Equity Ratio0.0%

How did BIOC perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.